|
Market Closed -
Nasdaq
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 3.740 USD | -1.84% |
|
-3.86% | -35.18% |
| 10-21 | Unicycive Therapeutics Shares Rise After FDA Accepts Resubmitted NDA | DJ |
| 10-21 | Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UNCY | Delayed | |
CBOE
| UNCY | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.23 | 5.63 | 5.63 |
| Spread/Res. | -11.58% | -33.57% | -33.57% |
| Spread/Supp. | +11.31% | +11.31% | +11.31% |
| Support | 3.36 | 3.36 | 3.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UNCY Stock
- Charts Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
